Novosanis Overview
- Year Founded
-
2013

- Status
-
Acquired/Merged
- Employees
-
20

- Latest Deal Type
-
M&A
- Investors
-
1
Novosanis General Information
Description
Developer of medical devices designed to improve the quality of diagnostics tests as well as the accuracy of drug delivery. The company's devices range from injection appliances to in vitro diagnostic accessories that are suited for the collection of first void urine which provides an improved diagnosis of sexually transmitted infections and cancer, thereby helping physicians to treat the patients.
Contact Information
Website
www.novosanis.com(Operating Subsidiary)
Corporate Office
- Bijkhoevelaan 32c
- 2110 Wijnegem
- Belgium
Corporate Office
- Bijkhoevelaan 32c
- 2110 Wijnegem
- Belgium
Novosanis Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
8. Merger/Acquisition | 04-Jan-2019 | Completed | Generating Revenue | |||
7. Angel (individual) | 10-Jul-2018 | Completed | Generating Revenue | |||
6. Grant | 04-Apr-2017 | Completed | Generating Revenue | |||
5. Angel (individual) | 26-Jan-2017 | Completed | Generating Revenue | |||
4. Grant | 15-Sep-2015 | Completed | Generating Revenue | |||
3. Grant | 13-Aug-2014 | Completed | Generating Revenue | |||
2. Seed Round | 19-Jul-2013 | $636K | $636K | Completed | Generating Revenue | |
1. University Spin-Out | 12-Mar-2013 | Completed | Startup |
Novosanis Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Class B | ||||||||
Class A | ||||||||
Class B | ||||||||
Class A | ||||||||
Class B | ||||||||
Class A | ||||||||
Class B | ||||||||
Class A | ||||||||
Class B | 18,000 | $24.97 | $24.97 | 1x | $24.97 | 8.82% | ||
Class B | 20,000 | $28.43 | $28.43 | 1x | $28.43 | 9.8% |
Novosanis Comparisons
Industry
Financing
Details
Novosanis Competitors (10)
One of Novosanis’s 10 competitors is ELITechGroup, a Formerly PE-Backed company based in Puteaux, France.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
ELITechGroup | Formerly PE-Backed | Puteaux, France | ||||
BacterioScan | Formerly VC-backed | Saint Louis, MO | ||||
LEX Diagnostics | Corporation | Melbourn, United Kingdom | ||||
Advanced Molecular Diagnostics | Corporation | Nottingham, United Kingdom | ||||
Lightpoint Medical | Formerly VC-backed | Amersham, United Kingdom |
Novosanis Patents
Novosanis Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
CA-217484-S | Floater for a liquid collection device | Active | 25-May-2022 | ||
EP-4045114-A1 | Needle adaptor and assembly for forming an injection device for administering a fluid to a subject | Pending | 16-Oct-2019 | ||
JP-2022552866-A | Needle adapter and assembly for forming an injection device for administering fluid to a subject | Pending | 16-Oct-2019 | ||
CA-3158194-A1 | Needle adaptor and assembly for forming an injection device for administering a fluid to a subject | Pending | 16-Oct-2019 | ||
EP-4041091-A2 | Small volume liquid sampler | Active | 07-Oct-2019 | A61B10/007 |
Novosanis Signals
Novosanis Former Investors (2)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Horizon 2020 SME Instrument | Government | Minority | ||
Taste Westerlund | Family Office | Minority |
Novosanis FAQs
-
When was Novosanis founded?
Novosanis was founded in 2013.
-
Where is Novosanis headquartered?
Novosanis is headquartered in Wijnegem, Belgium.
-
What is the size of Novosanis?
Novosanis has 20 total employees.
-
What industry is Novosanis in?
Novosanis’s primary industry is Medical Supplies.
-
Is Novosanis a private or public company?
Novosanis is a Private company.
-
What is Novosanis’s current revenue?
The current revenue for Novosanis is
. -
How much funding has Novosanis raised over time?
Novosanis has raised $2.12M.
-
Who are Novosanis’s investors?
Horizon 2020 SME Instrument and Taste Westerlund have invested in Novosanis.
-
Who are Novosanis’s competitors?
ELITechGroup, BacterioScan, LEX Diagnostics, Advanced Molecular Diagnostics, and Lightpoint Medical are some of the 10 competitors of Novosanis.
-
When was Novosanis acquired?
Novosanis was acquired on 04-Jan-2019.
-
Who acquired Novosanis?
Novosanis was acquired by Orasure Technologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »